Bonalive Orthopedics granules
Commercial- Indications
- Bone defects, Bacterial infections
Company intelligence / Profile preview
Bonalive Biomaterials
Turku, Finlandbonalive.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Commercial
01
Overview
Bonalive’s S53P4 bioactive glass has over 20 years of clinical history with more than 300 scientific articles supporting its efficacy. It has demonstrated effectiveness in promoting bone regeneration while preventing bacterial growth without antibiotics. The company’s lead product received FDA Breakthrough Device Designation for its potential to protect against microbial colonization[8]. Used in spinal surgeries, trauma surgeries, and infection-related procedures globally[4][5][9].
- Therapeutic areas
- OtherOncologyInfectious Diseases
- Modalities
- DeviceBiologic (bioactive glass)
- Industry
- Implantable Medical Devices
02
Drug pipeline
1 asset03
Partnerships
Distributor network across Europe/APAC/Africa/South Americamember of Terveysteknologia ry/HealthTech Finland
Beyond the preview
Go deeper on Bonalive Biomaterials.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bonalive Biomaterials.